Results 221 to 230 of about 59,113 (302)

Clinical Validation of Plasma p‐217tau in Neurological Diseases

Annals of Clinical and Translational Neurology, Volume 13, Issue 9, Page 1780-1790, September 2026.
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi, Takumi Nakamura, Ryoma Takahashi, Tetsuya Ueda, Seiji Kinoshita, Chikage Uchida, Takashi Sugawara, Kentaro Hashimoto, Kunihiko Ishizawa, Masakuni Amari, Hiroo Kasahara, Yoshio Ikeda, Masamitsu Takatama, Mikio Shoji   +13 more
wiley   +1 more source

Predicting pattern and spread of brain atrophy and tau deposition in progressive supranuclear palsy. [PDF]

Neuroimage Clin
Ghirelli A, Ali F, Stephens YC, Clark HM, Stierwalt JAG, Machulda MM, Agosta F, Filippi M, Dickson DW, Lowe VJ, Josephs KA, Whitwell JL, Satoh R.   +12 more
europepmc   +1 more source

PSP: Muurkrant

, 1977
PSP
core  

Network Topology Governs Photocatalytic Water Splitting in Organic Two‐Dimensional Crystals

Advanced Functional Materials, Volume 36, Issue 75, 17 September 2026.
Network topology in organic two‐dimensional crystals (O2DCs) dictates the photocatalytic water splitting performance. Kagome‐lattice O2DCs exhibit strong electron‐hole mass asymmetry, spatially separated carriers, and longer recombination lifetimes, exceeding rhombic isomers.
Preeti Bhauriyal, Thomas Heine
wiley   +1 more source

Pancreatic Stone Protein in Burns: Clinical Value of Bedside Testing-A Prospective Pilot Study. [PDF]

Diagnostics (Basel)
Billner M, Imhoff PV, Karcz K, Burchak V, Stumpfe MC, Soergel CA, Ehrl D.   +6 more
europepmc   +1 more source

PSP: aankondiging open avond PSP, 20 mei 1981

, 1981
PSP
core  

Mitochondria‐Targeted Nanotherapies in Aging Neurodegenerative Disorders: Emerging Prospects and Clinical Potential

Advanced Healthcare Materials, Volume 15, Issue 36, 25 September 2026.
Mitochondria‐targeted nanotherapies emerge as a promising strategy for combating aging‐associated neurodegenerative disorders (NDs) by restoring mitochondrial function, reducing oxidative stress, and improving neuronal survival. Recent advances in nanotechnology, therapeutic delivery, and translational research are highlighted, providing insights into ...
Dnyandev G. Gadhave, Ashish B. Jadhav, Nitin B. Waghamode, Shubham Khot, Rajiya Khan, Ravi Hole, Shankar M. Dhobale, Manoj Aswar, Keshav Raj Paudel   +8 more
wiley   +1 more source

Early assessment, diagnosis and treatment of Parkinsonism and Related Syndromes study (ExPRESS): a protocol for an observational study on incident parkinsonism. [PDF]

BMJ Open
Fumi RG, Caraiscos I, Jabbari E, Rittman T, Rowe JB, Ben-Shlomo Y, Hu MT, Morris HR.   +7 more
europepmc   +1 more source

Topology and Material Optimization in Ultra‐Soft Magneto‐Active Structures: Making Advantage of Residual Anisotropies

Advanced Materials, Volume 38, Issue 51, 11 September 2026.
Residual magnetization induces pronounced mechanical anisotropy in ultra‐soft magnetorheological elastomers, shaping deformation and actuation even without external magnetic fields. This study introduces a computational‐experimental framework integrating magneto‐mechanical coupling into topology optimization for designing soft magnetic actuators with ...
Carlos Perez‐Garcia, Rogelio Ortigosa, Jesús Martínez‐Frutos, Daniel Garcia‐Gonzalez   +3 more
wiley   +1 more source

Striatal Tau Pathology Underlies Monoaminergic Disruption in Progressive Supranuclear Palsy. [PDF]

Clin Nucl Med
Dong C, Ma JH, Qiao HW, Xu WQ, Gu ZQ, Barret O, Tamagnan GD, Mao W, Xu EH, Zhang C, Lu J, Chan P, Liu SY.   +12 more
europepmc   +1 more source